共 50 条
- [2] M-VAC AS SALVAGE CHEMOTHERAPY IN TRANSITIONAL CELL-CARCINOMA (TCC) OF THE UROTHELIUM PREVIOUSLY TREATED WITH CISPLATIN COMBINATION CHEMOTHERAPY PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 204 - 204
- [4] M-VAC (METHOTREXATE, VINBLASTINE, DOXORUBICIN AND CISPLATIN) FOR ADVANCED TRANSITIONAL CELL-CARCINOMA OF THE UROTHELIUM JOURNAL OF UROLOGY, 1988, 139 (03): : 461 - 469
- [5] INITIAL EXPERIENCE WITH M-VAC FOR METASTATIC TRANSITIONAL CELL-CARCINOMA (TCC) JOURNAL OF UROLOGY, 1987, 137 (04): : A270 - A270
- [6] CLINICAL DOWNSTAGING AFTER NEOADJUVANT M-VAC FOR TRANSITIONAL CELL-CARCINOMA OF THE UROTHELIUM JOURNAL OF UROLOGY, 1987, 137 (04): : A157 - A157
- [7] Maintenance chemotherapy with gemcitabine and paclitaxel for M-VAC refractory metastatic transitional cell carcinoma JOURNAL OF UROLOGY, 2005, 173 (04): : 360 - 360
- [8] M-VAC (METHOTREXATE, VINBLASTINE, DOXORUBICIN AND CISPLATIN) CHEMOTHERAPY FOR TRANSITIONAL CELL-CARCINOMA - THE PRINCESS-MARGARET-HOSPITAL EXPERIENCE JOURNAL OF UROLOGY, 1989, 142 (02): : 289 - 292
- [9] M-VAC CHEMOTHERAPY AND SURGERY FOR ADVANCED BLADDER-CARCINOMA AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1986, 9 (02): : 104 - 105
- [10] NEOADJUVANT M-VAC WITH INTRAARTERIAL (IA) CISPLATIN IN LOCALLY ADVANCED TRANSITIONAL CELL-CARCINOMA OF THE BLADDER - PHASE I/II TRIAL JOURNAL OF UROLOGY, 1987, 137 (04): : A156 - A156